Patience. At a minimum, a buyout floor has been set. There appears to have been an off-market share crossing of considerable weight which I take as good news. Unless of course it’s Merck selling those shares. We shall see.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025